Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$75K Sell
2,324
-2,475
-52% -$91.6K 0.05% 445
2025
Q4
$202K Sell
4,799
-2,653
-36% -$107K 0.11% 213
2025
Q3
$256K Buy
7,452
+3,281
+79% +$94.1K 0.14% 125
2025
Q2
$113K Buy
4,171
+1,527
+58% +$44.2K 0.07% 481
2025
Q1
$78K Buy
2,644
+2,633
+23,936% +$100K 0.05% 636
2024
Q4
$0 Sell
11
-2
-15% -$76 ﹤0.01% 2775
2024
Q3
$0 Sell
13
-9
-41% -$253 ﹤0.01% 2810
2024
Q2
$0 Hold
22
﹤0.01% 2794
2024
Q1
$1K Buy
22
+17
+340% +$415 ﹤0.01% 2135
2023
Q4
$0 Hold
5
﹤0.01% 2760
2023
Q3
$0 Sell
5
-1
-17% -$26 ﹤0.01% 2754
2023
Q2
$0 Hold
6
﹤0.01% 2692
2023
Q1
$0 Hold
6
﹤0.01% 2624
2022
Q4
$0 Sell
6
-1
-14% -$23 ﹤0.01% 2644
2022
Q3
$0 Sell
7
-1
-13% -$23 ﹤0.01% 2653
2022
Q2
$0 Sell
8
-3
-27% -$61 ﹤0.01% 2399
2022
Q1
$0 Sell
11
-2
-15% -$57 ﹤0.01% 2463
2021
Q4
$1K Buy
+13
New +$574 ﹤0.01% 1975

Other funds holding VCYT

Covestor's VCYT Position: Q1 2026 in Review

Covestor reduced its Veracyte (VCYT) stake by 52% in Q1 2026, selling an estimated $91.6K and leaving 2,324 shares worth $75K. The position accounts for 0.05% of the portfolio, ranked #445.

Covestor first reported a position in VCYT in Q4 2021 and has held it in 18 quarters since. The position peaked at $256K in Q3 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Covestor held 2,324 shares of Veracyte worth $75K as of Q1 2026.
  • Covestor sold 2,475 Veracyte shares in Q1 2026, an estimated $91.6K.
  • Veracyte made up 0.05% of Covestor's portfolio in Q1 2026, its #445 holding.
  • Covestor first reported a position in Veracyte in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Veracyte position peaked at $256K in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.